A Phase I/II Study of Diffuse Large B-cell Lymphoma
Conditions
- Refractory Diffuse Large B-cell Lymphoma
Interventions
- DRUG: Rituximab Paclitaxel Ruxolitinib
Sponsor
National Health Research Institutes, Taiwan
Collaborators
- [object Object]
- [object Object]
- [object Object]
- [object Object]